Slideshow
Author(s):
A study undertaken to evaluate the efficacy and tolerability of single pulse transcranial magnetic stimulation (sTMS) for the preventive treatment of migraine has led to an FDA extended indication.
System Integration: How AI Is Weaving Itself into Neurology
Sleeping Around the Podcast × NeurologyLive: Erenumab, Migraine, and Sleep
Testing Begins for RELIEV-CM2 Study of ShiraTronics Neuromodulation Device in Chronic Migraine
Sleeping Around the Podcast × NeurologyLive: Calcitonin Gene-Related Peptide in Sleep Research
FDA Approves Expanded Age Indication for Nerivio Migraine Device in Pediatric Patients
FDA Action Update, October 2024: Approvals, Acceptance, and Hold Removal